The Foxa2, Msx2, and Zeb2 transcription factors are known to play a role in the epithelial-to-mesenchymal transition [37, 38] and Reln is known to be epigenetically regulated and correlates with prognostic factors in human breast cancer [39]. Here, FOXA2 is linked to breast cancer.